Mary E. Pauzauskie, ARNP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 3208 Medical Park Dr, Shawnee, OK 74804 Phone: 405-878-7160 Fax: 405-878-7149 |
Mr. Joseph Charles Rawdon, APRN-CNS Clinical Nurse Specialist - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2810 N Kickapoo Ave, Shawnee, OK 74804 Phone: 405-585-0473 Fax: 405-585-0495 |
News Archive
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by Shire Development Inc. in connection with INTUNIVTM (guanfacine hydrochloride), 4 mg.
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.
A noninvasive electric stimulation technique administered to both sides of the brain can help stroke patients who have lost motor skills in their hands and arms, according to a new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted priority review status to the company's New Drug Application (NDA) for the investigational agent eribulin mesylate ("eribulin," also known as E7389). Eisai is seeking FDA approval for eribulin in the treatment of patients with locally advanced or metastatic breast cancer previously treated with at least two chemotherapy regimens, including an anthracycline and a taxane.
› Verified 5 days ago